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S
ince 2003, when PLoS Biology 
was launched, there has been 
a spectacular growth in “open-
access” journals. The Directory of 
Open Access Journals (http:⁄⁄www.
doaj.org/), hosted by Lund University 
Libraries, lists 2,816 open-access 
journals as this article goes to press 
(and probably more by the time you 
read this). Authors also have various 
“open-access” options within existing 
subscription journals offered by 
traditional publishers (e.g., Blackwell, 
Springer, Oxford University Press, and 
many others). In return for a fee to 
the publisher, an author’s individual 
article is made freely available and 
(sometimes) deposited in PubMed 
Central (PMC). But, as open access 
grows in prominence, so too has 
confusion about what open access 
means, particularly with regard to 
unrestricted use of content—which 
true open access allows. This confusion 
is being promulgated by journal 
publishers at the expense of authors 
and funding agencies wanting to 
support open access. 
Research funding agencies have 
been instrumental in driving the 
change toward open-access publishing. 
Many agencies now require the 
researchers they fund to make their 
articles freely available on publication, 
or within 6 or 12 months of publication 
(the most up-to-date information about 
such developments is available from 
the blog of Peter Suber, a leading 
scholar in the open-access movement 
[1]). The Wellcome trust, which has 
led the charge among funders, was 
also behind the recent launch of the 
European equivalent of PubMed 
Central (UKPMC; http:⁄⁄ukpmc.
ac.uk/), a free digital archive of 
biomedical and life sciences journal 
literature, which aims to mirror that 
created and hosted by the National 
Institutes of Health in the United 
States (http:⁄⁄www.pubmedcentral.nih.
gov/). European funding agencies are 
already responding to this resource. 
For example, within the United 
Kingdom, the Medical Research 
Council, the Department of Health, the 
British Heart Foundation, and Cancer 
Research UK all now require their 
grant holders to make their research 
articles available in UKPMC as soon as 
possible (and no later than six months) 
after publication. (Regular updates on 
open-access mandates and policies are 
available at http:⁄⁄www.eprints.org/
openaccess/policysignup/.) 
All these initiatives signal the 
ongoing transition from subscription-
based to open-access publishing of 
the scholarly research. It seems we 
are ﬁ  nally witnessing a sea change in 
scientiﬁ  c communication. But with this 
welcome trend comes a more insidious 
one to obscure the true meaning 
of open access by confusing it with 
free access. As the original Bethesda 
deﬁ  nition makes clear [2] (Box 1), 
open access allows for unrestricted 
derivative use; free access does not. So 
the beauty of open-access publishing 
is not just that you can download and 
read an article for personal use. You 
can also redistribute it, make derivative 
copies of it (such as reproducing it in 
another language; several PLoS Biology 
articles have been reproduced, in whole 
or in part, in Greek on http:⁄⁄www.
biology4u.gr), use it for educational 
purposes (e.g., [3]), or, most 
importantly, for purposes that we can’t 
yet envisage. This is because the open-
access license most commonly used—
the Creative Commons Attribution 
license (http:⁄⁄creativecommons.org/
licenses/)—permits derivative reuse, 
as long as the author is correctly cited 
and attributed for the work. It is the 
most liberal of the available Creative 
Commons licenses (there are six), 
which are now applied widely to books, 
music, videos, etc., as well as scholarly 
works. It is important to note that of 
the six different Creative Commons 
licenses, only those that permit 
unrestricted derivative use (which may 
be limited to noncommercial use) truly 
equate with open access.
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Box 1. The Bethesda Statement on Open-Access Publishing 
This is taken from http:⁄⁄www.earlham.edu/~peters/fos/bethesda.htm.
An Open Access Publication1 is one that meets the following two conditions: 
1. The author(s) and copyright holder(s) grant(s) to all users a free, irrevocable, 
worldwide, perpetual right of access to, and a license to copy, use, distribute, transmit 
and display the work publicly and to make and distribute derivative works, in any digital 
medium for any responsible purpose, subject to proper attribution of authorship2, as 
well as the right to make small numbers of printed copies for their personal use. 
2. A complete version of the work and all supplemental materials, including a copy of 
the permission as stated above, in a suitable standard electronic format is deposited 
immediately upon initial publication in at least one online repository that is supported 
by an academic institution, scholarly society, government agency, or other well-
established organization that seeks to enable open access, unrestricted distribution, 
interoperability, and long-term archiving (for the biomedical sciences, PubMed Central 
is such a repository). 
1Open access is a property of individual works, not necessarily journals or publishers. 
2Community standards, rather than copyright law, will continue to provide the 
mechanism for enforcement of proper attribution and responsible use of the published 
work, as they do now.PLoS Biology | www.plosbiology.org PLoS Biology | www.plosbiology.org 2096
New York Times science writer Carl 
Zimmer demonstrated the distinction 
succinctly [4]. He discusses a recent 
case where Wiley threatened legal 
action after a neuroscience graduate 
posted some ﬁ  gures from one of their 
journal articles on her blog (despite 
the fact that this is already permitted 
under terms of “fair dealing” or “fair 
use”). His response was:
“Compare Shelley’s experience 
to what I’m about to do. I’m going 
to—shudder—reprint a diagram from 
a journal. Just lift it straight out. ….And 
what do I now hear from PLOS? Do I 
hear the grinding of lawyerly knives? 
No. I hear the blissful silence of Open 
Access, a slowly-spreading trend in 
the journal world. PLOS makes it very 
clear on their web site that “everything 
we publish is freely available online 
throughout the world, for you to read, 
download, copy, distribute, and use 
(with attribution) any way you wish.” 
No muss, no fuss. If I want to blog 
about this paper right now, I can grab 
a relevant image right now from it. In 
fact, I just did.” [4]
Subsequent to an outcry within the 
blogoshpere (for a summary, see [5]), 
Wiley withdrew their threat of legal 
action. But the license that enabled 
Zimmer to extract the information he 
needed without worry is used by all 
the established open-access publishers, 
such as PLoS, BioMed Central, and 
Hindawi, as well as some traditional 
publishers, such as Oxford University 
Press (OUP). Examples of the license 
from some journals are given in Box 
2, and each statement is explicit about 
how the article may be used. In all 
cases, copyright is held by the authors, 
although this is not strictly necessary; as 
long as there is unrestricted derivative 
use, the copyright could be held by 
the author or the publisher and still be 
regarded as open access. 
Other journals purporting to be 
“open access” or publishers with an 
“open-access option” are not all that 
they seem. Take, for example, the 
journal Molecular Systems Biology. This 
is listed as an open-access journal by 
the DOAJ and published by the Nature 
Publishing Group. On the journal 
website (http:⁄⁄www.nature.com/msb/
index.html), there is a prominent link 
in the left hand column titled “open 
access.” Here, you are informed that 
the journal “makes primary research 
freely available to all researchers 
worldwide, ensuring maximum 
dissemination of content through the 
nature.com platform.” The publisher 
charges a publication fee (like PLoS) 
and publishes their content under a 
Creative Commons license (also like 
PLoS). But that’s where the similarities 
end. The Creative Commons license 
used is actually very different, despite 
the fact that at the bottom of the 
HTML version of any of their articles, 
there is a statement that the article 
is licensed under the “Attribution” 
license. However, when you click 
through to the full version, you are 
presented with the most restrictive 
Creative Commons license available, 
the “Attribution-Noncommercial-
No Derivative Works” license. The 
article can still be downloaded and 
redistributed (for personal use), but 
permission from the publisher is 
required for any additional derivative 
use (see also Box 2). What exactly have 
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Box 2. Examples of License Agreements and Open Access
Four of the ﬁ  ve journals, whose license statements are listed below, use a Creative 
Commons license (http:⁄⁄creativecommons.org/about/licenses/meet-the-licenses). 
Of these, PLoS Biology, BMC Biology, and Nucleic Acids Research conform to open 
access, as deﬁ  ned by the Bethesda Statement (Box 1). PLoS Biology and BMC Biology 
apply the Creative Commons “Attribution” (by) license to their articles, whereas 
Nucleic Acids Research applies the Creative Commons “Attribution Non-commercial” 
(by-nc) license. 
Molecular Systems Biology also applies a Creative Commons license to their articles, 
but this journal provides free access rather than open access, because they do not 
allow any derivative works to be made without permission. The particular license they 
use is the Creative Commons “Attribution Non-commercial No derivatives” (by-nc-nd) 
license. 
The journal Proceedings of the National Academy of Sciences (PNAS) does not use a 
Creative Commons license, but they do have a free access option. Their articles can be 
used for a wide range of purposes without permission, but the creation of derivative 
works is still restricted so this option is also not open access. 
Open Access (Permits Unrestricted Derivative Use):
•  PLoS Biology (http:⁄⁄plosbiology.org)
Copyright: © 2007 Jetz et al. This is an open-access article distributed under the 
terms of the Creative Commons Attribution License, which permits unrestricted 
use, distribution, and reproduction in any medium, provided the original author 
and source are credited.
•  BMC Biology (http:⁄⁄www.biomedcentral.com/bmcbiol/)
© 2007 Hoffman and Goodisman; licensee BioMed Central Ltd.
This is an Open Access article distributed under the terms of the Creative Commons 
Attribution License (http:⁄⁄creativecommons.org/licenses/by/2.0), which permits 
unrestricted use, distribution, and reproduction in any medium, provided the 
original work is properly cited.
•  Nucleic Acids Research (http:⁄⁄nar.oxfordjournals.org/)
© 2007 The Author(s) 
This is an Open Access article distributed under the terms of the Creative Commons 
Attribution Non-Commercial License (http:⁄⁄creativecommons.org/licenses/by-
nc/2.0/uk/) which permits unrestricted non-commercial use, distribution, and 
reproduction in any medium, provided the original work is properly cited.
Free Access (Does Not Permit Unrestricted Derivative Use): 
•  Molecular Systems Biology (http:⁄⁄www.nature.com/msb/index.html)
This is an open-access article distributed under the terms of the Creative Commons 
Attribution License, which permits distribution, and reproduction in any medium, 
provided the original author and source are credited. This license does not permit 
commercial exploitation or the creation of derivative works without speciﬁ  c 
permission.
© 2007 EMBO and Nature Publishing Group All rights reserved (on the pdf).
•  PNAS (http:⁄⁄www.pnas.org/)
Freely available online through the PNAS open access option.
© 2007 by The National Academy of Sciences of the USA.PLoS Biology | www.plosbiology.org PLoS Biology | www.plosbiology.org 2097
the authors—or, more likely, their 
funding agencies—agreed to pay for 
here? It is certainly not open access as 
deﬁ  ned by the Bethesda Statement [2].
Some journals do not claim to be 
fully open access but provide an “open-
access option” that permits articles 
to be deposited in PMC and thus 
conforms to the minimum guidelines 
set by, e.g., the Wellcome Trust. But 
confusion abounds here as well. If 
you search various journal sites for 
“open-access” options, you’ll ﬁ  nd it 
enormously difﬁ  cult to obtain clearly 
labeled information describing how 
you can use the article. Often an article 
is free to read, and has been deposited 
in the US PMC, but it’s not clear from 
the terms on the article that it can be 
distributed freely to others or reused 
without explicit permission from the 
appropriate permissions department. 
Again, this is not open access.
A particularly befuddling example 
comes from the Journal of Biological 
Chemistry (JBC). The JBC website states 
that it is an “open-access” journal and 
that their publisher—the American 
Society for Biochemistry and Molecular 
Biology (ASBMB)—is an “open-
access” publisher (http:⁄⁄www.jbc.
org/misc/JBC_Open_Access.shtml). 
They don’t charge a publication fee 
as such but do have page charges like 
many traditional journals (US$75 per 
published page). What you actually ﬁ  nd 
is that manuscripts that are currently 
in press are available for free but those 
published in the current issue are not. 
On the table of contents of the current 
issue, there is a helpful permissions 
button next to each article that links 
to a webpage that helps you calculate 
the charges for different uses (even for 
posting on the internet). It is unclear 
how this qualiﬁ  es as open access. 
Does the distinction between free 
and open access really matter if anyone 
can read the article for free? Isn’t 
open access just about making the 
literature available? Well, yes and no. 
Free access is certainly important, but 
it’s only the starting point. At least of 
equal importance is the potential for 
innovation. We don’t know yet what 
innovation means with regards to the 
full text of an article—who could have 
predicted the impact GenBank would 
have or the uses that sequences are now 
being put to? As one colleague put it, 
free access is like giving a child a Lego 
car and telling her that she can look at 
it, perhaps touch it, but certainly not 
take it apart and make an airplane from 
it. The full potential of the work cannot 
be realized [6].
What’s worrying is that there 
are already examples of publishers 
restricting use of their “free-access” 
articles, even in international 
repositories. For example, some of the 
publishers that currently allow their 
articles to be deposited in the US PMC 
will not allow those same articles to be 
mirrored and made available from the 
UK site (a list of these journals can be 
found at http:⁄⁄ukpmc.ac.uk/ppmc-
localhtml/not_in_ukpmc.html). It’s 
hard to understand the reasoning for 
this limitation—after all, the articles 
are freely available from the US site. 
But what’s disturbing is that publishers 
can act like this because the articles 
themselves are not truly open access—
who knows what further restrictions 
might be placed on these articles in the 
future.
So although true open access is 
unquestionably good for science, 
there is a real concern that the precise 
meaning of the term is being corrupted 
and eroded. Not all of the confusion 
about open access that currently 
permeates the scholarly publishing 
industry is likely to be intentional (at 
least not all of it); much arises from 
a genuine misunderstanding of open 
access by funders, authors, editors, and 
publishers alike. However, no matter 
how unintentional such obfuscation 
might be, it is detrimental to the free 
exchange and use of scholarly research. 
It is now time for all publishers to 
tighten the deﬁ  nition and application 
of open access and be clearer about 
the uses and restrictions applied to 
their articles. Open access is a term 
that should only be used when the 
license permits both free access and 
unrestricted derivative use (and gives 
appropriate attribution). Authors and 
funders need to be much more aware 
of the small print before inadvertently 
signing away their rights and those of 
their readers and, even worse, paying 
good money for the privilege. 
Perhaps the real key to establishing a 
broad consensus around the meaning of 
open access will be the development of 
resources that demonstrate the potential 
of unrestricted reuse of the literature—
the “Lego factor.” If certain work is not 
included in these resources because of 
restrictive license agreements, authors 
will probably pay much closer attention 
to the claim that a publisher is “open 
access.” Enlightened self-interest can be 
a powerful force.  
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